Weight change during breast cancer treatment: is it always of poor prognosis?
| Autor: | Gadea, Emilie, Ginzac, Angeline, Herviou, Pauline, Thivat, Emilie, Arbre, Marie, Morio, Béatrice, Durando, Xavier |
|---|---|
| Přispěvatelé: | Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), ProdInra, Migration |
| Jazyk: | francouzština |
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | Correspondances en Métabolismes, Hormones, Diabètes et Nutrition Correspondances en Métabolismes, Hormones, Diabètes et Nutrition, Edimark, 2015, 19 (10), pp.298-301 |
| ISSN: | 2100-9619 |
| Popis: | National audience; Weight change (gain or loss) is not uncommon in patients treated for breast cancer, especially when they receive chemotherapy. Weight changes observed during chemotherapy treatment performed before the 2000s, were associated with poor prognosis, but this relation is less found in more recent studies. Changes in body composition of women treated whith current chemotherapies remains to be determined. Post-treatment regular and moderate physical activity would reduce the risk of recurrence and mortality by 24-50%, both in obese and normal-weight women. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|